Calendar

Cloudflare's Q2 operating results and RPO growth were strong, but the pre-event tape deteriorated sharply: shares fell 15.4% from Oct. 26 through Oct. 30, with elevated volume on the down move, while software peers were weak. The checked sources establish Q3 consensus estimates but not positive quarter-specific estimate revisions or revenue upside; the setup fails required positive signals and the sector/relative-strength disqualifier.

Airbnb had credible Q3 EPS and revenue consensus and management previously described accelerating booking momentum, but pre-event shares were down about 4.43% over five sessions through Oct. 30, the latest close was near the bottom of its range, and no verified positive estimate revision or >1.5x-volume up day cleared the required tape gates.

EOG’s EPS consensus rose materially over the prior month and its last four reported quarters beat EPS consensus, with recent share-price gains; however, the checked tape does not establish the required close-location and 1.5x-volume conditions, XLE fell sharply on Nov. 2, and no positive revenue revision was verified. The setup does not clear the required tape and sector checks.

Lumentum’s company outlook and current consensus imply sharply higher year-over-year revenue and EPS, supported by reported AI/data-center demand and a recent run of quarterly EPS beats. The stock gained 11.2% over the five sessions through October 30 and had a strong close on October 28, but its 20-session trend remained weak, October 30’s high-volume decline and a sharp XLK selloff undermine confirmation; EPS/revenue revisions and whisper data were not independently established.

The company raised full-year Real Estate FFO guidance after Q2 and the supplied calendar confirms a Nov. 5 report; late-October shares rose, but there is no verified positive near-term estimate revision/upside indicator or volume accumulation, so the required setup is incomplete.

Natera’s investor-relations calendar confirms a November 5 Q3 call, and consensus sources estimate EPS of -$0.2812 and revenue of $707.54 million with a recent six-of-eight EPS beat record. However, no positive estimate revision or revenue-upside evidence was verified; the November 2 selloff closed near the session low, leaving required price and accumulation signals unmet.

Devon’s confirmed Nov. 5 release date and improving price trend provide some setup context, but the checked sources did not establish positive EPS revisions/ESP or revenue revisions, and available tape is mixed: Oct. 30 strength followed by a sharp Nov. 2 decline. With required estimate signals unverified, this is a non-qualifying, thin-data assessment.

The earnings date and both consensus measures were checked, and Atlassian’s prior quarter showed strong cloud growth and AI-product engagement. However, the stock fell sharply into the event: the Nov. 2 close was below the Oct. 30 close, and that day’s close location was weak. The checked sources did not establish positive current EPS revisions or revenue upside, so the positive business backdrop is insufficient for this pre-earnings setup.

Con Edison has a small positive whisper gap, recent earnings execution, reaffirmed 2026 guidance, and a supportive utilities tape. However, the whisper is only two cents above consensus, no positive estimate-revision trend was verified, the last three-session close locations were weak, and volume accumulation was not confirmed.

The recovery narrative is supported by Microchip’s August report of improving bookings, lower inventory days, stronger factory utilization, and September-quarter sales guidance above the prior-quarter level; however, the supplied pre-event tape is weak at the latest close, the available EPS estimate is approximately in line with company guidance, and the revenue consensus is above the guidance range rather than evidence of positive upside. Missing recent revision detail and sector-relative tape prevent a qualifying setup.

Live Nation confirms its Nov. 5 release and Q3 consensus implies year-over-year revenue growth, but ChartMill shows Q3 EPS estimates falling 20.03% over three months, with only a small revenue-estimate increase. The Nov. 2 close location was weak, and no recent volume accumulation was verified; unresolved antitrust litigation also weighs on risk hygiene.

Arm's investor-relations calendar lists its FY27 Q2 results on November 4, one day before the supplied calendar date, and an estimate source shows recent upward EPS estimate revisions. However, revenue upside and the required pre-event price/volume and sector checks were not verified, so the setup remains incomplete and below threshold.

The Nov. 6 date and both consensus estimates are reported by checked sources, but EPS estimates were revised lower and Zacks reported negative Earnings ESP; recent price recovery and visible oncology/pipeline catalysts do not overcome the absence of a positive earnings or revenue surprise signal.

BAM had a sharp, high-volume advance on Nov. 2 and strong reported fundraising and fee-related earnings momentum in its latest company update, but the available estimate sources conflict on consensus EPS and provide no verified positive near-term estimate revision or whisper gap; it therefore fails a required positive signal despite the improving business backdrop.

Humana confirmed its November 6 report date, and its prior-quarter report cited Medicare Advantage membership growth and improving retention; however, current-quarter EPS consensus is negative with more downward than upward revisions, the stock weakened into the event, and recent tape lacks the required close-location and volume signals.

Vistra’s Q2 adjusted EBITDA rose over 30% year over year and 2026 guidance was reaffirmed, but available EPS consensus sources diverged and did not establish positive revisions or a whisper edge. The stock was in a pronounced multi-session decline into the event, closing near the Nov. 2 low without abnormal volume support.

Monster has strong recent operating growth and a rising share price, but the checked consensus EPS estimate was revised down 0.75% over 30 days, and no positive revenue revision or upside indicator was established. The required close-location signal also was not verified above 0.75; despite a high-volume up day, the evidence does not support a qualifying pre-earnings setup.

Lindsay Corporation Announces Third Quarter Fiscal 2026 Earnings Conference Call and Webcast

Lindsay Corporation Announces Third Quarter Fiscal 2026 Earnings Conference Call and Webcast

Lindsay Corporation Announces Third Quarter Fiscal 2026 Earnings Conference Call and Webcast